All these evidences point out that the aberrant expression of UbcH10 could promote tumor expansion through dysfunction of mitotic progression, leading to deregulation of cell growth as confirmed in both thyroid [6] and breast carcinoma [8], where the interference with the UbcH10 expression significantly reduced the tumor cell proliferation. Here, UBE2C is linked to breast carcinoma.